Skip to content

Author

Connie Van

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Nov 2026

Implementation of pharmacist-led chronic kidney disease screening in Australian community pharmacies: feasibility and characteristics of the screened population.

BACKGROUND The Chronic Kidney Disease Screening and Quality Use of Medicines trial aimed to improve chronic kidney disease (CKD) detection and optimise medication use in Australia. This analysis evaluates the feasibility of pharmacy-based screening for identifying individuals at risk of CKD and reports participant base...

A. Korsa, I. Krass, Mimi Truong et al. · 0 citations
Open access Oct 2026

Towards safer medication practices: a retrospective analysis of adverse drug reactions

Under-reporting of adverse drug reactions (ADRs) to regulatory authorities remains a major challenge for pharmacovigilance, despite the substantial patient safety and financial implications of ADRs encountered in clinical practice. Reporting by healthcare professionals is persistently low; in 2017, only 19% of reports...

Jing-Xin Goh, Raymond Li, Fatima Small et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.